SCGPM Seminar: Tuval Ben Yehezkel

Event Information

Share this event

Date and Time

Location

Location

James H. Clark Center

318 Campus Dr

Seminar Room S360

Stanford, CA 94305

View Map

Refund Policy

Refund Policy

Contact the organiser to request a refund.

Event description

Description

LoopSeq™ single-molecule long-read sequencing

Tuval Ben Yehekzel, Loop Genomics, Founder & CEO

Friday, March 22nd
12:00 - 1:00PM
Clark S360
Lunch provided

The advent of next generation sequencing (NGS) technology has revolutionized our ability to read the genetic code, bringing about tremendous progress in our understanding of how biology is encoded in DNA and in medical diagnostics. However, while the throughput of NGS has improved by orders of magnitude compared to Sanger sequencing, NGS is limited to reading DNA in short segments of 150-300 nucleotides at a time. Biology, unfortunately, is not encoded in stretches of 150 nucleotides, but in much longer segments of DNA and RNA spanning many thousands of nucleotides.

Loop Genomics has developed a synthetic long read sequencing technology that leverages existing Illumina short read sequencers coupled with LoopSeq™ barcoding technology to enable single-molecule, long-read sequencing on any Illumina infrastructure.

In this talk, we will explore LoopSeq™ sequencing technology and how it is applied to provide additional, previously inaccessible layers of information from Illumina sequencers for a wide variety of sequencing applications as diverse as Microbiome, Transcriptome, Targeted Amplicons and others.

BIO: Tuval Ben Yehezkel is a scientist and entrepreneur who is focused on applied genomics and synthetic biology. After he completed his PhD and post-doctoral training at the Weizmann Institute of Science, he founded and ran two biotech startups, SynVaccine Ltd and Loop Genomics, which garnered a total of $15.3M in funding. He is currently the CEO at Loop Genomics.




ABOUT THE SCGPM: The Stanford Center for Genomics and Personalized Medicine (SCGPM) seeks to advance genomic technology so that someday both genetic and molecular profiling will become powerful and routine tools for predicting disease risk and monitoring and treating a wide range of pathologies. Towards this mission, the SCGPM serves to centralize and develop collaborative intellectual and technological resources that promote genomic research and analysis, predict drug response, educate physicians, and examine the ethics of personalized medicine. These efforts include large basic science projects such as ENCODE that decipher the human genome as well as clinical research projects such as the sequencing of cancer genomes and individuals with inherited diseases. Through these efforts, the Center aims to bring genomics to the clinic.

For more information about the SCGPM, go to http://scgpm.stanford.edu.

Share with friends

Date and Time

Location

James H. Clark Center

318 Campus Dr

Seminar Room S360

Stanford, CA 94305

View Map

Refund Policy

Contact the organiser to request a refund.

Save This Event

Event Saved